Null findings for circulating concentrations of LDL‐C, triglycerides, and ApoB refute a role of peripheral lipid modulation in the etiology of PD, providing a timely context to conflicting evidence from case‐control or prospective studies of lipid biomarkers or statin use.1, 2, 3, 4, 8. Here, APOB is linked to Parkinson disease.